eFFECTOR Therapeutics, Inc. (EFTR)
(Real Time Quote from BATS)
$1.40 USD
+0.02 (1.45%)
Updated Jun 7, 2024 10:28 AM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.74 | -16.43% |
Earnings Summary
For their last quarter, eFFECTOR Therapeutics, Inc. (EFTR) reported earnings of -$2.16 per share, beating the Zacks Consensus Estimate of $-2.17 per share. This reflects a positive earnings surprise of 0.46%. Look out for EFTR's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.74 per share, reflecting a year-over-year increase of 59.06%.
Earnings History
Price & Consensus
Zacks News for EFTR
Does eFFECTOR Therapeutics, Inc. (EFTR) Have the Potential to Rally 814.53% as Wall Street Analysts Expect?
EFTR: What are Zacks experts saying now?
Zacks Private Portfolio Services